POB2 REDUCING GLOBAL CARDIOMETABOLIC RISK IN OVERWEIGHT OR OBESE INDIVIDUALS WITH DYSLIPIDEMIA- PROJECTED BENEFITS OF RIMONABANT IN A REAL WORLD POPULATION
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65592-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)65592-1/fulltext
Title :
POB2 REDUCING GLOBAL CARDIOMETABOLIC RISK IN OVERWEIGHT OR OBESE INDIVIDUALS WITH DYSLIPIDEMIA- PROJECTED BENEFITS OF RIMONABANT IN A REAL WORLD POPULATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65592-1&doi=10.1016/S1098-3015(10)65592-1
First page :
Section Title :
Open access? :
No
Section Order :
751